Scientists prove that reducing the expression of a protein in the liver might attenuate liver fibrosis
Guillermo Mazzolini Rizzo, hepatologist and CONICET independent researcher at the Gene Therapy Laboratory of the School of Biomedical Sciences of the Austral University in Buenos Aires, has been studying for ten years the role of the osteonectin protein, or SPARC, in the hepatic fibrosis, a process that progressively replaces the hepatic tissue...